Skip to NavigationSkip to content

Pharmafile - Research and Development News

AMAG Pharmaceuticals announced that it will cut 30% of its staff, or 140 jobs, as part of a companywide restructuring.
Gilead Sciences has signed an exclusive licensing agreement with five generics drug companies in India and Pakistan to supply them with remdesivir.
Developments in treatments for COVID-19 continue to dominate the news, as the latest in hydroxychloroquine trials shows it does not help treat the...
Scientists are studying if senicapoc, a treatment for sickle cell anemia, can be repurposed to mitigate damage to a COVID-19 patient’s lungs.
South Korea says that remdesivir, traditionally used in treating Ebola, may not be effective enough in treating COVID-19 patients.
The FDA has moved to approve an oral tablet formulation of AstraZeneca’s Farxiga (dapagliflozin) to reduce the risk of cardiovascular death and...
Alexion has announced it is to acquire Boston-based blood disorder specialist Portola Pharmaceuticals in a transaction to the value of $1.41 billion...
Vaccines and treatments for COVID-19 continue to dominate the news, as two studies reveal "positive" data for Gilead's remdesivir in hospitalised...
Ousted Director of the Biomedical Advanced Research and Development Authority (BARDA), Dr Rick Bright, alleges the Trump administration ignored...
A new online reporting site has been launched by the Medicines and Healthcare products Regulatory Agency’s (MHRA) to track potential side-effects...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches